-
Mission, AbbVie Partner to Develop Parkinson’s, Alzheimer’s Therapies
Mission Therapeutics and AbbVie are partnering to develop inhibitors targeting deubiquitylating enzymes for Alzheimer’s and Parkinson’s diseases. Learn more here.
What are your thoughts on this news?
Sorry, there were no replies found.
Log in to reply.